References
- Regidor PA. Progesterone in peri- and prstmenopause: a review. Geburtshilfe Frauenheilkd. 2014;74:995–1002.
- Baber RJ, Panay N, Fenton A. 2016 IMS recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016;19:109–150.
- Nonhormonal management of menopause-associeted vasomotor symptoms: 2015 position statement of The North American Menopasue Society. Menopause. 2015;11:1155–1172.
- Archer DF, Sturdee DF, Baber R, et al. Menopausal hot flushes and night sweats: where are we now? Climacteric. 2011;14:515–528.
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–333.
- Lobo RA. Where are we 10 years after the women's health initiative? J Clin Endocrinol Metab. 2013;98:1771–1780.
- Espié M. Bouffées de chaleur et cancer du sein: Quelle prise en charge efficace et sans risque? Cancers au Féminin. 2013;1:1–16.
- de Lemos LM. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann Pharmacother. 2001;35:1118–1121.
- Orleans RJ, Li L, Kim MJ, et al. FDA approval of paroxetine for menopausal hot flushes. N Engl J Med. 2014;370:1777–1779.
- Zembutsu H, Sasa M, Kiyotani K, et al. Should CYP2D6 inhibitors be administered in conjunction with tamoxifen? Expert Rev Anticancer Ther. 2011;11:185–193.
- Hellström AC, Muntzing J. The pollen extract Femal - a nonestrogenic alternative to hormone therapy in women with menopausal symptoms. Menopause. 2012;19:825–829.
- Goldstein SR, Espié M, Druckman R. Does purifies Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system? Menopause. 2015;22(11):1212–1214
- Heinemann LAJ, Potthoff P, Schneider HPG. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcome. 2003;1:28–32.
- Winther K, Hedman CH. Assesment of the tolerance and effectiveness of a food suplement Fedal on the symptomps of prementrual syndrome. Current Ther Res. 2002;63:344–353.
- Gerhardsen G, Hansen AV, Killi M, et al. The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study. Adv Ther. 2008;25:595–607.
- Winther K, Rein E, Hedman C. Sérélys, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study. Climacteric. 2005;8:162–170.
- Elia D, Mares P. Assessment of the tolerance and effectiveness of the food supplement Sérélys® for menopausal women. Genesis. 2008;135:12–15.
- Druckmann R. Non-hormonal treatment of vasomotor symptoms in female patients with and after breast carcinoma. Maturitas. 2015;81: 160.
- Freeman EW, Ensrud KE, Larson JC, et al. Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors. Psychosom Med. 2015;77:167–175.
- Seeger H, Ruan X, Neubauer H, et al. Membrane-initiated effects of Serelys® on proliferation and apoptosis of human breast cancer cells. Gynecol Endocrinol. 2017;27:1–4.